Does Gadoxetic acid-enhanced 3.0T MRI in addition to 64-detector-row contrast-enhanced CT provide better diagnostic performance and change the therapeutic strategy for the preoperative evaluation of colorectal liver metastases?

European Radiology

Volumn 24, Issue 10, 2014, Pages 2532-2539

  Sofue, Keitaro ^a,b   Tsurusaki, Masakatsu ^a,c   Murakami, Takamichi ^c   Onoe, Shunsuke ^a   Tokue, Hiroyuki ^a   Shibamoto, Kentaro ^a   Arai, Yasuaki ^a   Sugimura, Kazuro ^b  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KINKI UNIVERSITY   (Japan)

Author keywords

Colorectal liver metastases; Contrast enhanced computed tomography; Diagnostic performance; Gadoxetic acid enhanced magnetic resonance imaging; Therapeutic strategy

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM PENTETATE; GADOXETIC ACID;

AGED; COLON RESECTION; COLORECTAL NEOPLASMS; COMPARATIVE STUDY; DIAGNOSTIC USE; FEMALE; HUMAN; IMAGE ENHANCEMENT; LIVER NEOPLASMS; LIVER RESECTION; MALE; MIDDLE AGED; MULTIDETECTOR COMPUTED TOMOGRAPHY; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PRACTICE GUIDELINE; PREOPERATIVE CARE; PROCEDURES; RADIOGRAPHY; RECEIVER OPERATING CHARACTERISTIC; SECONDARY; STANDARDS;

AGED; COLECTOMY; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HEPATECTOMY; HUMANS; IMAGE ENHANCEMENT; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIDETECTOR COMPUTED TOMOGRAPHY; PRACTICE GUIDELINES AS TOPIC; PREOPERATIVE CARE; ROC CURVE;

EID: 84930250185     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-014-3233-7     Document Type: Article

References (20)

1. Manfredi S, Lepage C, Hatem C, Coatmeur O, Faivre J, Bouvier AM (2006) Epidemiology and management of liver metastases from colorectal cancer. Ann Surg 244:254–259
2. Charnsangavej C, Clary B, Fong Y, Grothey A, Pawlik TM, Choti MA (2006) Selection of patients for resection of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol 13:1261–1268
3. Frankel TL, Gian RK, Jarnagin WR (2012) Preoperative imaging for hepatic resection of colorectal cancer metastasis. J Gastrointest Oncol 3:11–18
4. von Falkenhausen MM, Lutterbey G, Morakkabati-Spitz N, Walter O, Gieseke J, Blömer R et al (2006) High-field-strength MR imaging of the liver at 3.0 T: intraindividual comparative study with MR imaging at 1.5 T. Radiology 241:156–166
5. Huppertz A, Haraida S, Kraus A, Zech CJ, Scheidler J, Breuer J et al (2005) Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT—initial observations. Radiology 234:468–478
6. Ward J (2006) New MR techniques for the detection of liver metastases. Cancer Imaging 6:33–42
7. Zech CJ, Herrmann KA, Reiser MF, Schoenberg SO (2007) MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent Gd-EOB-DTPA. Magn Reson Med Sci 6:43–52
8. Hammerstingl R, Huppertz A, Breuer J, Balzer T, Blakeborough A, Carter R et al (2008) Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions. Eur Radiol 18:457–467
9. Muhi A, Ichikawa T, Motosugi U, Sou H, Nakajima H, Sano K et al (2011) Diagnosis of colorectal hepatic metastases: comparison of contrast-enhanced CT, contrast-enhanced US, superparamagnetic iron oxide-enhanced MRI, and gadoxetic acid-enhanced MRI. J Magn Reson Imaging 34:326–335
10. Kim YK, Park G, Kim CS, Yu HC, Han YM (2012) Diagnostic efficacy of gadoxetic acid-enhanced MRI for the detection and characterization of liver metastases: comparison with multidetector-row CT. Br J Radiol 85:539–547
11. Scharitzer M, Ba-Ssalamah A, Ringl H, Kölblinger C, Grünberger T, Weber M et al (2013) Preoperative evaluation of colorectal liver metastases: comparison between gadoxetic acid-enhanced 3.0-T MRI and contrast-enhanced MDCT with histopathological correlation. Eur Radiol 23:2187–2196
12. Berger-Kulemann V, Schima W, Baroud S, Koelblinger C, Kaczirek K, Gruenberger T et al (2012) Gadoxetic acid-enhanced 3.0 T MR imaging versus multidetector-row CT in the detection of colorectal metastases in fatty liver using intraoperative ultrasound and histopathology as a standard of reference. Eur J Surg Oncol 38:670–676
13. Sofue K, Tsurusaki M, Tokue H, Arai Y, Sugimura K (2011) Gd-EOB-DTPA-enhanced 3.0 T MR imaging: quantitative and qualitative comparison of hepatocyte-phase images obtained 10 min and 20 min after injection for the detection of liver metastases from colorectal carcinoma. Eur Radiol 21:2336–2343
14. Chang KJ, Kamel IR, Macura KJ, Bluemke DA (2008) 3.0-T MR imaging of the abdomen: comparison with 1.5 T. Radiographics 28:1983–1998
15. Goshima S, Kanematsu M, Watanabe H, Kondo H, Shiratori Y, Onozuka M et al (2010) Hepatic hemangioma and metastasis: differentiation with gadoxetate disodium-enhanced 3-T MRI. AJR Am J Roentgenol 195:941–946
16. Tateyama A, Fukukura Y, Takumi K, Shindo T, Kumagae Y, Kamimura K et al (2012) Gd-EOB-DTPA-enhanced magnetic resonance imaging features of hepatic hemangioma compared with enhanced computed tomography. World J Gastroenterol 18:6269–6276
17. Motosugi U, Ichikawa T, Sou H, Sano K, Tominaga L, Kitamura T et al (2009) Liver parenchymal enhancement of hepatocyte-phase images in Gd-EOB-DTPA-enhanced MR imaging: which biological markers of the liver function affect the enhancement? J Magn Reson Imaging 30:1042–1046
18. Kim YK, Lee MW, Lee WJ, Kim SH, Rhim H, Lim JH et al (2012) Diagnostic accuracy and sensitivity of diffusion-weighted and of gadoxetic acid-enhanced 3-T MR imaging alone or in combination in the detection of small liver metastasis (≤1.5 cm in diameter). Investig Radiol 47:159–166
19. Donati OF, Fischer MA, Chuck N, Hunziker R, Weishaupt D, Reiner CS (2013) Accuracy and confidence of Gd-EOB-DTPA enhanced MRI and diffusion-weighted imaging alone and in combination for the diagnosis of liver metastases. Eur J Radiol 82:822–828
20. Seo HJ, Kim MJ, Lee JD, Chung WS, Kim YE (2011) Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases. Investig Radiol 46:548–555